Mutations Position Table

MAPT R5 Mutations

Tools

Back to the Top
Mutation Pathogenicity DNA Change Expected RNA | Protein Consequence Coding/Non-Coding Genomic Region Neuropathology Biological Effect Primary
Papers
R5H
FTD : Unclear Pathogenicity, AD : Not Classified Substitution Substitution | Missense Coding Exon 1

In one case, neuronal loss in the frontal and temporal lobes; tau deposits predominantly in glia, progressive supranuclear palsy-like straight tubules; accumulation of 4-repeat (4R), Sarkosyl-insoluble tau.

 

Promoted fibril formation in vitro, but not in a cell-based assay. Reduced microtubule assembly in vitro; increased microtubule binding in cells.

Hayashi et al., 2002
R5L
FTD : Uncertain Significance Substitution Substitution | Missense Coding Exon 1

Aggregated insoluble tau in subcortical regions was predominantly 4-repeat (4R) tau with 0 or 1 amino terminal inserts (i.e. 0N4R or 1N4R). Insoluble tau in cortical regions also contained 1N3R tau.

Mixed results regarding effects on microtubule dynamics and tau aggregation. Multiple cellular processes affected in a Drosophila model.

Poorkaj et al., 2002
R5C
FTD : Uncertain Significance, PDD : Not Classified Substitution Substitution | Missense Coding Exon 1

Unknown, but MRI of two carriers showed frontal atrophy, with one also having temporal atrophy and the other microangiopathy. FDG-PET showed hypoperfusion in frontal and temporal lobes of one carrier.

Unknown, but PHRED-scaled CADD score (20.4) predicted a damaging effect.

Schulte et al., 2015

Disclaimer: Alzforum does not provide medical advice. The Content is for informational, educational, research and reference purposes only and is not intended to substitute for professional medical advice, diagnosis or treatment. Always seek advice from a qualified physician or health care professional about any medical concern, and do not disregard professional medical advice because of anything you may read on Alzforum.